| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.052 | 0.3 |